John O. Fleming, MD Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
John O. Fleming, MD, is a Professor of Neurology at the University of Wisconsin School of Medicine and Public Health. His medical interests include multiple sclerosis, viral infections of the central nervous system and hygiene hypothesis. Dr. Fleming’s teaching interests consist of multiple sclerosis, central nervous system infections and bioethics.
UW Health Clinics
UW School of Medicine and Public Health
|Department of Neurology|
Professional Certifications and Education
University of Southern California
Northshore University Hospital, Cornell University
Kings County Hospital, Brooklyn, NY
State University of New York, Brooklyn, NY, 1971
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.
- Lumbar Puncture
Programs & Conditions
Dr. Fleming’s research currently consists of clinical trials of multiple sclerosis therapies, advanced neuroimaging in multiple sclerosis, animal models of viral-induced demyelination, immunochemistry of viruses and viral evolutions and persistence.
Fleming JO Carlsson CM .
Biomarkers for neurology: Guides and lines. Neurology. 2014 Sep 23;83(13):1130-1
[PubMed ID: 25150288]
Hosseinbor AP Chung MK Wu YC Fleming JO Field AS Alexander AL .
Extracting quantitative measures from EAP: a small clinical study using BFOR. Med Image Comput Comput Assist Interv. 2012;15(Pt 2):280-7
[PubMed ID: 23286059]
Fleming JO Cook TD .
Multiple sclerosis and the hygiene hypothesis. Neurology. 2006 Dec 12;67(11):2085-6
[PubMed ID: 17159130]
Wu Y Alexander AL Fleming JO Duncan ID Field AS .
Myelin water fraction in human cervical spinal cord in vivo. J Comput Assist Tomogr. 2006 Mar-Apr;30(2):304-6
[PubMed ID: 16628052]
Fee DB Fleming JO .
Resolution of chronic inflammatory demyelinating polyneuropathy-associated central nervous system lesions after treatment with intravenous immunoglobulin. J Peripher Nerv Syst. 2003 Sep;8(3):155-8
[PubMed ID: 12904236]